Abstract
Priapism is defined as an erection lasting longer than 4 h that is not associated with sexual stimulation. It is generally classified into two etiologies: ischemic and nonischemic. The former, comprising the vast majority of cases, is considered an emergency due to the associated pain as well as to structural changes in the penis that may lead to penile fibrosis and severe erectile dysfunction. Conservative management is rarely effective except in select circumstances. Interventions may include aspiration of the corpora, injection of vasoconstrictive agents, or surgical procedures. Nonischemic priapism presents fewer emergent risks andmay be followed conservatively. If intervention is necessary, angiographic embolization is often the best therapeutic option.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Adeyoju AB, Olujohunabe AG, Morris J et al (2002) Priapismin sickle-cell disease; incidence, risk factors and complications — an international multicentre study. BJU Int 90:898
Ahmed I, Shaikh NA (1997) Treatment of intermittent idiopathic priapism with oral terbutaline. Br J Urol 80:341
Altman AL, Seftel AD, Brown SL et al (1999) Cocaine associated priapism. J Urol 161:1817
Avisrror MU, Fernandez IA, Sanchez AS et al (2000) Doxazosin and priapism. J Urol 163:238
Baba H, Maezawa Y, Furusawa N et al (1995) Lumbar spinal stenosis causing intermittent priapism. Paraplegia 33:338
Barry JM (1976) Priapism: treatment with corpus cavernosum to dorsal vein of penis shunts. J Urol 116:754
Bastuba MD, Saenz de Tejada I, Dinlenc CZ et al (1994) Arterial priapism: diagnosis, treatment and long-term followup. J Urol 151:1231
Bechara A, Casabe A, Cheliz G et al (1997) Comparative study of papaverine plus phentolamine versus prostaglandin E1 in erectile dysfunction. J Urol 157:2132
Benjelloun S, el Mrini M, Aboutaieb R et al (1993) Priapism. A propos of 10 cases (translation). J Urol (Paris) 99:91
Bialecki ES, Bridges KR (2002) Sildenafil relieves priapism in patients with sickle cell disease. Am J Med 113:252
Bochinski DJ, Dean RC, Lue TF (2004) Erectile dysfunction and priapism. Nat Clin Pract Urol 1:49
Brock G, Breza J, Lue TF et al (1993) High flow priapism: a spectrum of disease. J Urol 150:968
Bschleipfer TH, Hauck EW, Diemer TH et al (2001) Heparininduced priapism. Int J Impot Res 13:357
Bucy JG (1968) Removal of strangulating objects from the penis. J Urol 99:194
Burnett AL, Allen RP, Tempany CM et al (1995) Evaluation of erectile function in men with sickle cell disease. Urology 45:657
Compton MT, Miller AH (2001) Priapism associated with conventional and atypical antipsychotic medications: a review. J Clin Psychiatry 62:362
Dahm P, Rao DS, Donatucci CF (2002) Antiandrogens in the treatment of priapism. Urology 59:138
De Pablo Cardenas A, Jimenez Calvo JM, Grasa Lanau V et al (1999) High-flow priapism in the pediatric age: review (translation). Arch Esp Urol 52:862
Detweiler MB (2001) Penile incarceration withmetal objects-a review of procedure choice based on penile trauma grade. Scand J Urol Nephrol 35:212
Drachenberg D, Nguan C, Norman RW et al. (1999) Penile entrapment injury: a case report. Can J Urol 6:709
Earle CM, Stuckey BG, Ching HL et al (2003) The incidence and management of priapismin Western Australia: a 16 year audit. Int J Impot Res 15:272
Ekman P, Sjogren L, Englund G et al (2000) Optimizing the therapeutic approach of transurethral alprostadil. BJU Int 86:68
El-Bahnasawy MS, Dawood A, Farouk A (2002) Low-flow priapism: risk factors for erectile dysfunction. BJU Int 89:285
Fernandez Arancibia MI, Martinez Portillo FJ, Musial A et al (2000) Diagnosis and therapeutic options for prolonged erection and priapism: up-date review (translation). Arch Esp Urol 53:919
Francis RB Jr, Johnson CS (1991) Vascular occlusion in sickle cell disease: current concepts and unanswered questions. Blood 77:1405
Goldmeier D, Lamba H (2002) Drug points: prolonged erections produced by dihydrocodeine and sildenafil. BMJ 324: 1555
Govier FE, Jonsson E, Kramer-Levien DA (1994) Oral terbutaline for the treatment of priapism. J Urol 151:878
Hatzichristou D, Salpiggidis G, Hatzimouratidis K et al (2002) Management strategy for arterial priapism: therapeutic dilemmas. J Urol 168:2074
Hebuterne X, Frere AM, Bayle J et al (1992) Priapism in a patient treated with total parenteral nutrition. JPEN J Parenter Enteral Nutr 16:171
Ilkay AK, Levine LA (1995) Conservative management of highflow priapism. Urology 46:419
Keoghane SR, Sullivan ME, Miller MA (2002) The aetiology, pathogenesis and management of priapism. BJU Int 90:149
Kimber RM, Mellon JK (2004) The role of special cutting equipment and corporeal aspiration in the treatment of penile incarceration with a barbell retaining collar. J Urol 172:975
King SH, Hallock M, Strote J et al (2005) Tadalafil-associated priapism. Urol 66:432
Kulmala R, Lehtonen T, Nieminen P et al (1995) Aetiology of priapism in 207 patients. Eur Urol 28:241
Kulmala RV, Lehtonen TA, Tammela TL (1996) Preservation of potency after treatment for priapism. Scan J Urol Nephrol 30:313
Kvarstein B (1996) Bladder cancer complicated with priapism. A case report. Scand J Urol Nephrol Suppl 179:155
Lehtonen T, Tenhunen A (1973) Treatment of idiopathic priapism by Grayhack’s caverno-saphenous shunt. Scand J Urol Nephrol 7:233
Linet OI, Neff LL (1994) Intracavernous prostaglandin E1 in erectile dysfunction. Clin Investig 72:139
Linet OI, Ogrinc FG (1996) Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. The Alprostadil Study Group. N Engl J Med 334:873
Lowe FC, Jarow JP (1993) Placebo-controlled study of oral terbutaline and pseudoephedrine in management of prostaglandin E1-induced prolonged erections. Urology 42:51
Marx FJ (1981) Therapy of priapism (translation). Urologe A 20:353
McMahon CG (2002) High flow priapism due to an arterial-lacunar fistula complicating initial veno-occlusive priapism. Int J Impot Res 14:195
Melman A, Serels S (2000) Priapism. Int J Impot Res Suppl 12:S133
Muruve N, Hosking DH (1996) Intracorporeal phenylephrine in the treatment of priapism. J Urol 155:141
Nelson JH 3rd, Winter CC (1977) Priapism: evolution of management in 48 patients in a 22-year series. J Urol 117:455
Nixon RG, O’Connor JL, Milam DF (2003) Efficacy of shunt surgery for refractory low flow priapism: a report on the incidence of failed detumescence and erectile dysfunction. J Urol 170:883
Noh J, Kang TW, Heo T et al (2004) Penile strangulation treated with the modified string method. Urology 64:591
Okpala I, Westerdale N, Jegede T et al (2002) Etilefrine for the prevention of priapism in adult sickle cell disease. Br J Haematol 118:918
Papadopoulos I, Kelami A (1988) Priapus and priapism. From mythology to medicine. Urology 32:385
Quigley M, Fawcett DP (1999) Thrombophilia and priapism. BJU Int 83:155
Quackels R (1964) Cure of patient suffering from priapism by cavernospongiosal anastomosis. Acta Urol Belg 32:5
Rourke KF, Fischler AH, Jordan GH (2002) Treatment of recurrent idiopathic priapism with oral baclofen. J Urol 168:2552
Sadeghi-Nejad H, Seftel AD (2002) The etiology, diagnosis, and treatment of priapism: review of the American Foundation for Urologic Disease Consensus Panel report. Curr Urol Rep 3:492
Santucci RA, Deng D, Carney J (2004) Removal of metal penile foreign body with a widely available emergency-medicalservices-provided air-driven grinder. Urology 63:1183
Schroeder-Printzen I, Vosshenrich R, Weidner R et al (1994) Malignant priapism in a patient with metastatic prostate adenocarcinoma. Urol Int 52:52
Secil M, Arslan D, Goktay AY et al (2001) The prediction of papaverine induced priapism by color Doppler sonography. J Urol 165:416
Shantha TR, Finnerty DP, Rodriquez AP (1989) Treatment of persistent penile erection and priapism using terbutaline. J Urol 141:1427
Soliman SM, Hafie E, Hassan TA et al (2003) Hair coil induced penile tourniquet injury. Saudi Med J 24:S55
Spycher MA, Hauri D (1986) The ultrastructure of the erectile tissue in priapism. J Urol 135:142
Steinberg J, Eyre RC (1995) Management of recurrent priapism with epinephrine self-injection and gonadotropin-releasing hormone analogue. J Urol 153:152
Sur RL, Kane CJ (2000) Sildenafil citrate-associated priapism. Urology 55:950
Vahasarja VJ, Hellstrom PA, Serlo W et al (1993) Treatment of penile incarceration by the string method: 2 case reports. J Urol 149:372
Voegeli TA, Effert PJ (2005) Pentaethylene-terephthalate (PET) bottles: a new device for autoerotic strangulation of the penis causing serious injury. Arch Sex Behav 34:469
Witt MA, Goldstein I, Saenz de Tejada I et al (1990) Traumatic laceration of intracavernosal arteries: the pathophysiology of non-ischemic, high flow, arterial priapism. J Urol 143:129
Zargooshi J (2000) Priapismas a complication of high dose testosterone therapy in a man with hypogonadism. J Urol 163:907
Zisman A, Lindner A (1993) Recurrent intermittent priapism following priapism (translation). Harefuah 125:85
Zorgniotti AW, Lefleur RS (1985) Auto-injection of the corpus cavernosum with a vasoactive drug combination for vasculogenic impotence. J Urol 133:39
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Brant, W.O., Bella, A.J., Gracia, M.M., Lue, T.F. (2007). Priapism. In: Hohenfellner, M., Santucci, R.A. (eds) Emergencies in Urology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-48605-3_24
Download citation
DOI: https://doi.org/10.1007/978-3-540-48605-3_24
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-48603-9
Online ISBN: 978-3-540-48605-3
eBook Packages: MedicineMedicine (R0)